![]() |
|
|
Department of Nutrition and Food Management, Oregon State University, Corvallis, OR 97331 and * Department of Food Science and Human Nutrition, Washington State University, Pullman, WA 99164
3To whom correspondence should be addressed. E-mail: leklemj{at}orst.edu.
To examine the effect of increased intake levels of vitamin B-6 (B-6) on lymphocyte proliferation and interleukin 2 (IL-2) concentration, young women (n = 7) consumed a constant diet containing 1 mg (5.91 µmol) B-6/d for a 7-d adjustment period, followed by three 14-d experimental periods during which the daily B-6 intake was 1.5, 2.1 and 2.7 mg (8.86, 12.41 and 15.95 µmol)/d, respectively. Weekly fasting blood and daily 24-h urine samples were collected. Lymphocyte proliferation and IL-2 production were measured in response to phytohemagglutinin. Vitamin B-6 status improved with increased B-6 intake as measured by plasma pyridoxal 5'-phosphate (PLP) and urinary 4-pyridoxic acid. When subjects consumed 2.1 mg B-6/d for 7 d, lymphocyte proliferation increased by 35% (P
0.05) compared with the mean value after consumption of 1.5 mg B-6/d for 14 d. There was no further enhancement after an additional week of 2.1 and 2.7 mg B-6/d for 2 wk. Lymphocyte proliferation was correlated (P
0.01) with vitamin B-6 intake (r = 0.757), plasma PLP (r = 0.456) and erythrocyte aminotransferase activities (r = -0.361). Plasma IL-2 concentration and in vitro production did not change throughout the study, although five of seven subjects showed increases with intakes of 2.1 and 2.7 mg B-6/d, respectively, compared with the 1.5 mg/d intake. Concentrations of PLP in peripheral blood mononuclear cells were correlated (r = 0.357, P
0.01) with plasma PLP, but not with proliferation. These results show that improving vitamin B-6 status by consuming a B-6 intake higher than the current Recommended Dietary Allowance enhances lymphocyte proliferation.
KEY WORDS: vitamin B-6 status young women peripheral blood mononuclear cells lymphocyte proliferation interleukin 2
This article has been cited by other articles:
![]() |
A. T Vasilaki, D. C McMillan, J. Kinsella, A. Duncan, D. S. J O'Reilly, and D. Talwar Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness Am. J. Clinical Nutrition, July 1, 2008; 88(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koutros, Y. Zhang, Y. Zhu, S. T. Mayne, S. H. Zahm, T. R. Holford, B. P. Leaderer, P. Boyle, and T. Zheng Nutrients Contributing to One-Carbon Metabolism and Risk of Non-Hodgkin Lymphoma Subtypes Am. J. Epidemiol., February 1, 2008; 167(3): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boynton, M. L Neuhouser, M. H Wener, B. Wood, B. Sorensen, Z. Chen-Levy, E. A Kirk, Y. Yasui, K. LaCroix, A. McTiernan, et al. Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1445 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Ren and S. Melmed Pyridoxal Phosphate Inhibits Pituitary Cell Proliferation and Hormone Secretion Endocrinology, August 1, 2006; 147(8): 3936 - 3942. [Abstract] [Full Text] [PDF] |
||||